Voglio sapere a riguardo di…

lotter on DSK11XQN23PROD with RULES1

Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Rules and Regulations the requester refers to any nonpublic information other than its own, the requester shall obtain a written right of reference to that nonpublic information and submit the right of reference with the request. Any reference to published information offered in support of a request should be accompanied by reprints or copies of such references.
b Requests shall be submitted and addressed to the Document Control Unit HFV199, Center for Veterinary Medicine, Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855. Requests may be submitted in an electronic format as authorized by FDA. See FDAs Electronic Submissions Gateway website: https www.fda.gov/industry/
electronic-submissions-gateway.
c Any material submitted in a foreign language shall be accompanied by a complete and accurate English translation. Translations of literature printed in a language other than English shall be accompanied by copies of the original publication.
d The request must be dated and must be signed by the requester or by his or her authorized attorney, agent, or official and shall state the requesters correspondence address. If the requester or such authorized representative does not reside or have a place of business within the United States, the requester must also furnish the name and post office address of, and the request must be countersigned by, an authorized attorney, agent, or official residing or maintaining a place of business within the United States.
e The request must include the following information:
1 The established name and all pertinent information concerning the new animal drug, including chemical identity and composition of the new animal drug, and its physical, chemical, and biological properties;
2 The conditions of use for the new animal drug, including the route of administration and dosage, together with all labeling, directions, and recommendations regarding the uses in countries in which the new animal drug is lawfully used;
3 The proposed import tolerances for residues of the new animal drug;
4 Human food safety information to support the proposed import tolerances in either of the following forms:
i If a permanent maximum residue limit MRL has been established by the Codex Alimentarius Committee Codex MRL, the requester shall provide the permanent Codex MRL and monographs and reports from the Joint Expert Committee on Food Additives JECFA

VerDate Sep<11>2014

16:53 Sep 20, 2021

Jkt 253001

of the Food and Agriculture Organization FAO and the World Health Organization WHO of the United Nations and/or monographs and reports from the Joint FAO/WHO
Meeting on Pesticide Residues JMPR
that support the development of the permanent Codex MRL. FDA may request additional information as needed.
ii If no permanent Codex MRL has been established, or upon notification by FDA, the requester must provide full reports of investigations made with respect to the human food safety of the new animal drug. A request may be regarded as incomplete unless it includes full reports of adequate tests by all methods reasonably applicable to show whether or not any imported edible portion of any animal receiving the new animal drug will be safe for human consumption. The reports must include detailed data derived from appropriate animal and other biological experiments in which the methods used and the results obtained are clearly set forth, including data submitted to the appropriate regulatory authority in any country where the new animal drug is lawfully used. The request must also include a statement that all such reports have been submitted or contain an explanation of why such reports were not submitted. With respect to each nonclinical laboratory study contained in the request, the requestor must submit either a statement that the study was conducted in compliance with the good laboratory practice regulations set forth in part 58 of this chapter, or, if the study was not conducted in compliance with such regulations, a brief statement of the reason for the noncompliance, and how this may have impacted the study;
5 Other human food safety information as deemed necessary by the Commissioner;
6 A description of practicable methods for determining the quantity, if any, of the new animal drug in or on food, and any substance formed in or on food because of its use;
7 An environmental assessment under 25.40 of this chapter; and 8 Any information required under 500.80 through 500.92 of this chapter Subpart E, Regulation of Carcinogenic Compounds Used in Food-Producing Animals, where applicable.
f A request to amend an established import tolerance must contain information to support each proposed change. The request may omit statements made in the original request for which no change is proposed.
g The requester may withdraw the request at any time before the
PO 00000

Frm 00017

Fmt 4700

Sfmt 4700

52411

notification provided for in 510.207a of this chapter has been made publicly available.
510.206 Review of information supporting actions to establish or amend an import tolerance.

In establishing or amending an import tolerance, the Commissioner shall rely on data sufficient to demonstrate that a proposed tolerance is safe based on similar food safety criteria used by the Commissioner to establish tolerances for applications for new animal drugs filed under section 512b1 of the Federal Food, Drug, and Cosmetic Act. In establishing or amending an import tolerance, the Commissioner will give appropriate consideration to the anticipated residue concentrations and conditions of use of the new animal drug specified.
510.207 Disclosure of information submitted in a request.

a When a request is determined to be complete for FDAs consideration, the Commissioner will provide public notification of the request containing the name of the requester and a brief description of the request in general terms. A copy of the notification will be sent to the requester at the time the information is made available to the public.
b Any notification establishing, amending, or revoking an import tolerance will be made publicly available. A summary of the basis for the decision will be publicly released in accordance with the provisions of part 20 of this chapter. If FDA determines that the new animal drug referred to in the request is a new animal drug that induces cancer when ingested by people or animals, and the requester complies with the requirements of 500.80
through 500.92 of this chapter Subpart E, Regulation of Carcinogenic Compounds Used in Food-Producing Animals, the regulatory method for ascertaining the marker residue in the target tissue will be made publicly available. All information and safety data submitted with the request, or previously submitted information incorporated in, and considered as part of, a request on the basis of specific reference to such information, shall be available for public disclosure, also in accordance with the provisions of part 20 of this chapter. Trade secrets and confidential commercial or financial information are exempted from release under 20.61 of this chapter.
510.209 Establishment, denial, or amendment of an import tolerance.

a If an import tolerance is established or amended, the
E:FRFM21SER1.SGM

21SER1